Zai Lab Limited has secured $250 million in a private placement through the sale of 11,340,000 American Depositary Shares. The financing was facilitated via a securities purchase agreement with selected investors.
PUBLIC · ZLABOct 23, 2026
Amount Raised
$250 Million
Round Type
Post-IPO Equity
ShanghaiBiotechnologyHealth CareBiopharma
Description
Zai Lab Limited has announced a $250 million private placement. The company will issue 11,340,000 American Depositary Shares at a price of $22.04 per share. This private investment in public equity (PIPE) will provide substantial capital for its innovative biopharma initiatives. The funding underscores investor confidence in Zai Lab's growth potential.
Who to call at Zai Lab Limited, and when
A new round usually means Zai Lab Limited is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Zai Lab Limited raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Zai Lab Limited, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Zai Lab Limited
Location
Shanghai, China
About
Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. The company focuses on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in oncology, immunology, neuroscience, and infectious disease. Zai Lab aims to leverage its competencies and resources to positively impact human health in China and worldwide.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zai Lab Limited raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ShanghaiBiotechnologyHealth CareBiopharma